RU93000552A - DRUGS FUGENTIN - Google Patents

DRUGS FUGENTIN

Info

Publication number
RU93000552A
RU93000552A RU93000552/14A RU93000552A RU93000552A RU 93000552 A RU93000552 A RU 93000552A RU 93000552/14 A RU93000552/14 A RU 93000552/14A RU 93000552 A RU93000552 A RU 93000552A RU 93000552 A RU93000552 A RU 93000552A
Authority
RU
Russia
Prior art keywords
nose
fugentin
ear
drug
drugs
Prior art date
Application number
RU93000552/14A
Other languages
Russian (ru)
Other versions
RU2077327C1 (en
Inventor
Э.З. Каган
Н.И. Синицына
Л.К. Граковская
И.П. Фомина
А.Н. Лобусева
А.В. Никитин
Г.В. Долгова
Т.И. Скоблик
Т.И. Юдина
Original Assignee
Государственный научный центр по антибиотикам
Фармацевтическое акционерное общество "Ферейн"
Filing date
Publication date
Application filed by Государственный научный центр по антибиотикам, Фармацевтическое акционерное общество "Ферейн" filed Critical Государственный научный центр по антибиотикам
Priority to RU93000552A priority Critical patent/RU2077327C1/en
Priority claimed from RU93000552A external-priority patent/RU2077327C1/en
Publication of RU93000552A publication Critical patent/RU93000552A/en
Application granted granted Critical
Publication of RU2077327C1 publication Critical patent/RU2077327C1/en

Links

Claims (1)

Лекарственное средство Фугентин (капли ушные/носовые) относится к медицине, в частности к лекарственным препаратам, используемым для лечения заболеваний уха и носа. Разработанный препарат предназначен для лечения инфекционных заболеваний уха, носа и профилактики послеоперационных осложнений на придаточных пазухах носа. В состав капель Фугентин введены антибиотики фузидиевой кислоты и гентамицин сульфата. Капли Фугентин не вызывают нежелательных побочных эффектов, являясь практически нетоксичным препаратом.The drug Fugentin (ear / nose drops) refers to medicine, in particular to drugs used to treat diseases of the ear and nose. The developed drug is intended for the treatment of infectious diseases of the ear, nose and the prevention of postoperative complications in the sinuses of the nose. Fuzentin antibiotics of fusidic acid and gentamicin sulfate are added to the composition of droplets. Drops Fugentin do not cause undesirable side effects, being practically non-toxic drug.
RU93000552A 1993-01-05 1993-01-05 Medicinal agent RU2077327C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU93000552A RU2077327C1 (en) 1993-01-05 1993-01-05 Medicinal agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU93000552A RU2077327C1 (en) 1993-01-05 1993-01-05 Medicinal agent

Publications (2)

Publication Number Publication Date
RU93000552A true RU93000552A (en) 1995-05-10
RU2077327C1 RU2077327C1 (en) 1997-04-20

Family

ID=20135270

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93000552A RU2077327C1 (en) 1993-01-05 1993-01-05 Medicinal agent

Country Status (1)

Country Link
RU (1) RU2077327C1 (en)

Similar Documents

Publication Publication Date Title
CA2116559A1 (en) Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
HUT51136A (en) Process for producing pharmaceutical compositions for treating schisophreny, containing l-deprenil as active component
CA2118121A1 (en) Methods and compositions for the treatment of diseases with interferon while reducing side effects
AU1358695A (en) Nasal administration
DE69230046D1 (en) 2-bromomelatonin for the treatment of sleep disorders
GEP20002298B (en) Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment
BR9609063A (en) Dinucleotides useful for the treatment of lung diseases
DE69815122D1 (en) SACCHARID-CONTAINING PREPARATIONS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER AMYLOIDOSES
BR9507506A (en) Process to exterminate a cell process for cancer treatment composition and therapeutic kit
BRPI9509286B8 (en) drug and / or nutritional microcapsules for administration per se.
CA2289717A1 (en) Novel therapy for constipation
CA2215692A1 (en) Method of modulating microcirculation
ATE99172T1 (en) USE OF ACETYL-L-CARNITINE IN TREATMENT OF CATARACT, AND PHARMACEUTICAL COMPOSITIONS FOR SUCH TREATMENT.
KR890003387A (en) Double-stranded RMAs Composition with Local Activity
DE69210802D1 (en) PHARMACEUTICAL AEROSOL PREPARATION AND THEIR USE FOR TREATING AND PROPHYLAXIS OF VIRAL DISEASES
AU7425391A (en) Use of n-alkylated 1, 4-dihydropyridinedicarboxylic acid esters as medicaments, new compounds and processes for their preparation
CA2143610A1 (en) Use of norastemizole for the treatment of allergic disorders
DK0668077T3 (en) Products containing G-CSF and TNF-binding protein
CA2020346A1 (en) Antibiotic ge 2270 factors a1, a2, a3 and h
CA2037779A1 (en) Antibiotic ge 2270 factors b1, b2, c1, c2, d1, d2, e and t
RU93000552A (en) DRUGS FUGENTIN
KR900701278A (en) Bile acids for the treatment of viral infections
EP0228239A3 (en) Preparation of a medicament for arthritis and rheumatism
MY111746A (en) Therapeutic nucleosides.
KR960003718A (en) Use of Ifenprodil and its Diastereomers for the Preparation of Medicines Useful for the Treatment of Peripheral and Central Neurodegenerative Diseases